| Towards a better understanding of GABAergic remodeling in Alzheimer’s disease K Govindpani, B Calvo-Flores Guzmán, C Vinnakota, HJ Waldvogel, ... International journal of molecular sciences 18 (8), 1813, 2017 | 194 | 2017 |
| Vascular dysfunction in Alzheimer’s disease: a prelude to the pathological process or a consequence of it? K Govindpani, LG McNamara, NR Smith, C Vinnakota, HJ Waldvogel, ... Journal of clinical medicine 8 (5), 651, 2019 | 182 | 2019 |
| The role of microglia and astrocytes in Huntington’s disease TH Palpagama, HJ Waldvogel, RLM Faull, A Kwakowsky Frontiers in molecular neuroscience 12, 258, 2019 | 179 | 2019 |
| The GABAergic system as a therapeutic target for Alzheimer's disease B Calvo‐Flores Guzmán, C Vinnakota, K Govindpani, HJ Waldvogel, ... Journal of neurochemistry 146 (6), 649-669, 2018 | 145 | 2018 |
| GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus A Kwakowsky, B Calvo‐Flores Guzmán, M Pandya, C Turner, ... Journal of neurochemistry 145 (5), 374-392, 2018 | 93 | 2018 |
| Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus TE Fuhrer, TH Palpagama, HJ Waldvogel, BJL Synek, C Turner, RL Faull, ... Neuroscience 351, 108-118, 2017 | 81 | 2017 |
| Sex-and age-related changes in GABA signaling components in the human cortex M Pandya, TH Palpagama, C Turner, HJ Waldvogel, RL Faull, ... Biology of sex differences 10, 1-16, 2019 | 70 | 2019 |
| Current and possible future therapeutic options for Huntington’s disease MW Ferguson, CJ Kennedy, TH Palpagama, HJ Waldvogel, RLM Faull, ... Journal of Central Nervous System Disease 14, 11795735221092517, 2022 | 53 | 2022 |
| Impaired expression of GABA signaling components in the Alzheimer’s disease middle temporal gyrus K Govindpani, C Turner, HJ Waldvogel, RLM Faull, A Kwakowsky International journal of molecular sciences 21 (22), 8704, 2020 | 51 | 2020 |
| Treatment of beta amyloid 1–42 (Aβ1–42)-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo A Kwakowsky, K Potapov, SH Kim, K Peppercorn, WP Tate, IM Ábrahám Scientific reports 6 (1), 21101, 2016 | 47 | 2016 |
| Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway A Kwakowsky, BCF Guzmán, K Govindpani, HJ Waldvogel, RL Faull Neural regeneration research 13 (8), 1362-1363, 2018 | 43 | 2018 |
| Effect of estradiol on neurotrophin receptors in basal forebrain cholinergic neurons: Relevance for Alzheimer’s disease A Kwakowsky, MR Milne, HJ Waldvogel, RL Faull International journal of molecular sciences 17 (12), 2122, 2016 | 41 | 2016 |
| The acute effects of amyloid-beta1–42 on glutamatergic receptor and transporter expression in the mouse hippocampus JHY Yeung, TH Palpagama, WP Tate, K Peppercorn, HJ Waldvogel, ... Frontiers in neuroscience 13, 494393, 2020 | 37 | 2020 |
| GAD isoforms exhibit distinct spatiotemporal expression patterns in the developing mouse lens: correlation with Dlx2 and Dlx5 A Kwakowsky, M Schwirtlich, Q Zhang, DD Eisenstat, F Erdélyi, M Baranyi, ... Developmental dynamics: an official publication of the American Association …, 2007 | 33 | 2007 |
| The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons A Kwakowsky, AE Herbison, IM Ábrahám Journal of Neuroscience 32 (33), 11309-11317, 2012 | 32 | 2012 |
| Estradiol acts directly and indirectly on multiple signaling pathways to phosphorylate cAMP-response element binding protein in GnRH neurons RY Cheong, A Kwakowsky, Z Barad, R Porteous, AE Herbison, ... Endocrinology 153 (8), 3792-3803, 2012 | 32 | 2012 |
| Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo MR Milne, CA Haug, IM Ábrahám, A Kwakowsky Endocrinology 156 (2), 613-626, 2015 | 29 | 2015 |
| Is hormone replacement therapy a risk factor or a therapeutic option for Alzheimer’s disease? ZB Mills, RLM Faull, A Kwakowsky International Journal of Molecular Sciences 24 (4), 3205, 2023 | 27 | 2023 |
| Glutamatergic receptor expression changes in the Alzheimer's disease hippocampus and entorhinal cortex JHY Yeung, JL Walby, TH Palpagama, C Turner, HJ Waldvogel, ... Brain Pathology 31 (6), e13005, 2021 | 26 | 2021 |
| Amyloid‐beta1–42 induced glutamatergic receptor and transporter expression changes in the mouse hippocampus JHY Yeung, B Calvo‐Flores Guzmán, TH Palpagama, J Ethiraj, Y Zhai, ... Journal of Neurochemistry 155 (1), 62-80, 2020 | 23 | 2020 |
